2. Academic Validation
  3. Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?

Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?

  • Oncotarget. 2018 Dec 18;9(99):37280-37281. doi: 10.18632/oncotarget.26460.
Toby A Eyre 1
Affiliations

Affiliation

  • 1 Toby A. Eyre: Early Phase Trials Unit, University of Oxford, Oxford, UK; Department of Clinical Haematology, Oxford Cancer Centre, Churchill Hospital, Oxford, UK.
PMID: 30647865 DOI: 10.18632/oncotarget.26460
Keywords

CXD101; HDAC inhibitor; HR23B; Hodgkin lymphoma; T cell lymphoma.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-100748
    99.81%, HDAC1/2/3 Inhibitor